Deerfield Mgmt HIF, L.P.'s Net Worth
$1.69 Billion
Who is Deerfield Mgmt HIF, L.P.?
Deerfield Mgmt HIF, L.P. has an estimated net worth of $1.69 Billion. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Larimar Therapeutics, Inc., Homology Medicines, Inc., and Oncorus, Inc..
SEC CIK
Deerfield Mgmt HIF, L.P.'s CIK is 0001665736
Past Insider Trading and Trends
2020 was Deerfield Mgmt HIF, L.P.'s most active year for acquiring shares with 14 total transactions. Deerfield Mgmt HIF, L.P.'s most active month to acquire stocks was the month of August. 2022 was Deerfield Mgmt HIF, L.P.'s most active year for disposing of shares, totalling 39 transactions. Deerfield Mgmt HIF, L.P.'s most active month to dispose stocks was the month of November. 2020 saw Deerfield Mgmt HIF, L.P. paying a total of $40,000,000.00 for 8,130,683 shares, this is the most they've acquired in one year. In 2020 Deerfield Mgmt HIF, L.P. cashed out on 57,002,139 shares for a total of $18,052,380.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Editas Medicine, Inc. (EDIT) Snapshot price: $7.145
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.81M |
$16.00 |
—
| 1.81M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nuvalent, Inc. (NUVL) Snapshot price: $78.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 650K |
$33.50 | $21,775,000.00 | 650K |
Nov 3
| |||
Form 4
| +3,369.86% | 18.78M |
—
|
—
| 19.34M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.17% | -38.48K |
$25.01 | -$962,255.52 | 3.24M |
Jun 6
| |||
Form 4
| -100.00% | -99.33K |
$15.81 | -$1,570,328.25 |
0
|
Jul 9
| |||
Form 4
| -40.17% | -66.67K |
$16.29 | -$1,086,221.55 | 99.33K |
Jul 2 - Jul 7
| |||
Form 4
|
∞
| 3.45M |
$15.00 | $2,490,000.00 | 3.45M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GRAYBUG VISION, INC. (CALC) Snapshot price: $5.6772
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.28M |
$16.00 |
—
| 5.28M |
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $5.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.11% | 4.29M |
$8.74 | $37,499,992.58 | 16.51M |
Feb 16
| |||
Form 4
| +190.58% | 11.11M |
$3.15 | $34,999,990.20 | 16.94M |
Sep 16
| |||
Form 4
| +13.33% | 685.71K |
$8.75 | $5,999,962.50 | 5.83M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |